Citigroup’s OncoSec Medical Incorporated ONCS Stock Holding History

Citigroup’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13	Closed	-$22	–	6101
2022 Q4	$22	Buy	+13	New	+$73	﹤0.01%	5699
2022 Q1	–	Sell	-5	Closed	–	–	6883
2021 Q4	$0	Buy	+5	New	+$169	﹤0.01%	6273
2021 Q3	–	Sell	-186	Closed	-$12K	–	6576
2021 Q2	$12K	Buy	+186	New	+$16.9K	﹤0.01%	5602
2018 Q2	–	Sell	-5	Closed	-$2K	–	7831
2018 Q1	$2K	Hold	5	–	–	﹤0.01%	7402
2017 Q4	$2K	Hold	5	–	–	﹤0.01%	7438
2017 Q3	$1K	Hold	5	–	–	﹤0.01%	7209
2017 Q2	$1K	Hold	5	–	–	﹤0.01%	7280
2017 Q1	$1K	Hold	5	–	–	﹤0.01%	7142
2016 Q4	$1K	Hold	5	–	–	﹤0.01%	7147
2016 Q3	$2K	Hold	5	–	–	﹤0.01%	6949
2016 Q2	$2K	Sell	5 -1	-17%	-$421	﹤0.01%	6950
2016 Q1	$4K	Buy	6 +1	+20%	+$426	﹤0.01%	7102
2015 Q4	$2K	Hold	5	–	–	﹤0.01%	7315
2015 Q3	$5K	Buy	5 +3	+150%	+$3.93K	﹤0.01%	6774
2015 Q2	$3K	Buy	+2	New	+$3K	﹤0.01%	7052

Other funds holding ONCS

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup's ONCS Position: Q1 2023 in Review

Citigroup sold out of OncoSec Medical Incorporated (ONCS) in Q1 2023, closing a stake of 13 shares — an estimated $22 sold.

Citigroup first reported a position in ONCS in Q2 2015 and held it in 15 quarters. The position peaked at $12K in Q2 2021. 12 funds tracked by Wall St. Rank hold ONCS as of Q1 2023.

Citigroup reported no remaining OncoSec Medical Incorporated position as of Q1 2023 after selling out during the quarter.
Citigroup sold 13 OncoSec Medical Incorporated shares in Q1 2023, an estimated $22.
Citigroup first reported a position in OncoSec Medical Incorporated in Q2 2015 and held it in 15 quarters.
Citigroup's OncoSec Medical Incorporated position peaked at $12K in Q2 2021.
12 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2023.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.